Skip to main content

Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies.

Publication ,  Journal Article
Mukherjee, C; Caron, MG; Mullikin, D; Lefkowitz, RJ
Published in: Mol Pharmacol
January 1976

Duke Scholars

Published In

Mol Pharmacol

ISSN

0026-895X

Publication Date

January 1976

Volume

12

Issue

1

Start / End Page

16 / 31

Location

United States

Related Subject Headings

  • Structure-Activity Relationship
  • Receptors, Adrenergic
  • Rana pipiens
  • Protein Binding
  • Pharmacology & Pharmacy
  • Kinetics
  • In Vitro Techniques
  • Animals
  • Adrenergic beta-Antagonists
  • Adrenergic beta-Agonists
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mukherjee, C., Caron, M. G., Mullikin, D., & Lefkowitz, R. J. (1976). Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies. Mol Pharmacol, 12(1), 16–31.
Mukherjee, C., M. G. Caron, D. Mullikin, and R. J. Lefkowitz. “Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies.Mol Pharmacol 12, no. 1 (January 1976): 16–31.
Mukherjee C, Caron MG, Mullikin D, Lefkowitz RJ. Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies. Mol Pharmacol. 1976 Jan;12(1):16–31.
Mukherjee C, Caron MG, Mullikin D, Lefkowitz RJ. Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies. Mol Pharmacol. 1976 Jan;12(1):16–31.

Published In

Mol Pharmacol

ISSN

0026-895X

Publication Date

January 1976

Volume

12

Issue

1

Start / End Page

16 / 31

Location

United States

Related Subject Headings

  • Structure-Activity Relationship
  • Receptors, Adrenergic
  • Rana pipiens
  • Protein Binding
  • Pharmacology & Pharmacy
  • Kinetics
  • In Vitro Techniques
  • Animals
  • Adrenergic beta-Antagonists
  • Adrenergic beta-Agonists